Serge Saxonov - 17 Mar 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Issuer symbol
TXG
Transactions as of
17 Mar 2025
Net transactions value
$0
Form type
4
Filing time
19 Mar 2025, 17:35:44 UTC
Previous filing
04 Mar 2025
Next filing
27 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +171,428 +19% $0.000000 1,092,968 17 Mar 2025 Direct F1
holding TXG Class A Common Stock 27 17 Mar 2025 See footnote F2
holding TXG Class A Common Stock 870 17 Mar 2025 See footnote F3
holding TXG Class A Common Stock 213,250 17 Mar 2025 See footnote F4
holding TXG Class A Common Stock 22,570 17 Mar 2025 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.